Skip to main content

Search form

You are here

Thomas Anthony D'Amico, MD

Gary Hock Distinguished Professor of Surgery
Director, Integrated Thoracic Surgery Residency Program and Joint General Surgery and Thoracic Surgery Residency Program
Director, Advanced Training in Cardiothoracic Surgery
Professor of Surgery
Division: 
Cardiovascular and Thoracic Surgery
Program: 
General Surgery Residency Program
Office: Duke South - 3589 White Zone, Durham, NC 27710
Campus Mail: DUMC Box 3496 Med Ctr, Durham, NC 27710

Lung Cancer

1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations

Esophageal Cancer

1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations

Education and Training

  • M.D., Columbia University, 1987

Selected Grants

Publications

Rice, David C., Jeremy J. Erasmus, Craig W. Stevens, Ara A. Vaporciyan, Judy S. Wu, Anne S. Tsao, Garrett L. Walsh, et al. “Extended surgical staging for potentially resectable malignant pleural mesothelioma.” Ann Thorac Surg, December 2005. https://doi.org/10.1016/j.athoracsur.2005.06.014.

Full Text

Burfeind, William R., Thomas A. D’Amico, Eric M. Toloza, Walter G. Wolfe, and David H. Harpole. “Low morbidity and mortality for bronchoplastic procedures with and without induction therapy.” Ann Thorac Surg 80, no. 2 (August 2005): 418–21. https://doi.org/10.1016/j.athoracsur.2005.02.058.

Full Text

Lemaire, Anthony, William R. Burfeind, Eric Toloza, Scott Balderson, Rebecca P. Petersen, David H. Harpole, and Thomas A. D’Amico. “Outcomes of tracheobronchial stents in patients with malignant airway disease.” Ann Thorac Surg 80, no. 2 (August 2005): 434–37. https://doi.org/10.1016/j.athoracsur.2005.02.071.

Full Text

Kahn, Daniel, Sumin Zhou, Sung-Ja Ahn, Donna Hollis, Xiaoli Yu, Thomas A. D’Amico, Timothy D. Shafman, and Lawrence B. Marks. “"Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics.” Int J Radiat Oncol Biol Phys 62, no. 3 (July 1, 2005): 645–51. https://doi.org/10.1016/j.ijrobp.2004.10.042.

Full Text

Harpole, D., M. B. M. Joshi, R. P. Petersen, C. C. Miller, D. Conlon, K. R. Brooks, and T. A. D’Amico. “Monitoring tumor markers in serial sera predicts disease failure in lung cancer patients following surgery.” In Journal of Clinical Oncology, 23:630S-630S. AMER SOC CLINICAL ONCOLOGY, 2005.

Scholars@Duke

Jaklitsch, M. T., L. Gu, D. H. Harpole, T. A. D’Amico, R. J. McKenna, M. J. Krasna, L. J. Kohman, S. J. Swanson, M. M. Decamp, and D. J. Sugarbaker. “Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803.” In Journal of Clinical Oncology, 23:636S-636S. AMER SOC CLINICAL ONCOLOGY, 2005.

Scholars@Duke

Kocak, Z., X. Yu, S. M. Zhou, T. A. D’Amico, D. Hollis, D. Kahn, A. Tisch, T. D. Shafman, and L. B. Marks. “The impact of pre-radiotherapy surgery on radiation-induced lung injury.” Clin Oncol (R Coll Radiol) 17, no. 4 (June 2005): 210–16. https://doi.org/10.1016/j.clon.2004.11.013.

Full Text

Pages